Palivizumab
Paul A. Pham, Pharm.D. BCPS, Paul G. Auwaerter, M.D.
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
- Prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV) in pediatric patients at high risk of RSV disease (bronchopulmonary dysplasia, premature birth, and hemodynamically significant congenital heart disease).
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Treatment of severe RSV pneumonia in immunocompromised adult patients (limited data).
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2025 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.